Jiang Shirley X, Schwab Katerina, Hussaini Trana, Omar Mahmoud, Cox Ben, Marquez-Azalgara Vladimir, Yoshida Eric M
Medicine, University of British Columbia, Vancouver, CAN.
Pharmaceutical Sciences, University of British Columbia, Vancouver, CAN.
Cureus. 2022 Nov 21;14(11):e31760. doi: 10.7759/cureus.31760. eCollection 2022 Nov.
Compared to other recreational substances in Canada, alcohol consumption incurs the highest healthcare costs. Liver transplant recipients are unique stakeholders as members of the general public with lived experiences of liver disease. We sought to explore their perspectives on the current state of public education on alcohol-related health effects.
The most recent 400 liver transplant recipients at Vancouver General Hospital, Canada, were invited to participate in an anonymous online survey on alcohol-related health effects by mail, email, and phone.
Of 372 contacted patients, 212 (57%) completed the survey. Most patients were between 60-79 years, 63% were male, and 69% were Caucasian. The most common liver conditions leading to transplant were viral hepatitis (33%), alcohol-related liver disease (16%), autoimmune liver disease (14%), and non-alcoholic fatty liver disease (15%). Most patients knew that alcohol leads to liver failure (85%), but fewer knew about alcohol leading to cancer (54%), heart disease (50%), and damage to other organs (58%). Most common sources of information included public media (61%), family and friends (52%), and physicians (49%), with narrative comments about learning of alcohol-related health effects after liver diagnosis. Most patients believed that public health education at a middle/high school level would have long-term efficacy (72%) compared to health warning labels (33%) and safety messaging in commercials (39%). Current public education was felt to be adequate by only 20% of patients and 73% of patients supported health warning labels.
Liver transplant patients reported a high, but not universal, awareness of alcohol-related health effects. A majority thought that current public health efforts were inadequate; it is critical to implement public health interventions to ensure consumers are able to make an informed decision on alcohol consumption.
与加拿大的其他消遣性物质相比,酒精消费产生的医疗费用最高。肝移植受者作为有肝病亲身经历的普通公众成员,是独特的利益相关者。我们试图探讨他们对当前酒精相关健康影响公众教育现状的看法。
邀请加拿大温哥华总医院最近的400名肝移植受者通过邮件、电子邮件和电话参与一项关于酒精相关健康影响的匿名在线调查。
在联系的372名患者中,212名(57%)完成了调查。大多数患者年龄在60 - 79岁之间,63%为男性,69%为白种人。导致移植的最常见肝脏疾病是病毒性肝炎(33%)、酒精性肝病(16%)、自身免疫性肝病(14%)和非酒精性脂肪性肝病(15%)。大多数患者知道酒精会导致肝衰竭(85%),但较少有人知道酒精会导致癌症(54%)、心脏病(50%)和对其他器官的损害(58%)。最常见的信息来源包括大众媒体(61%)、家人和朋友(52%)以及医生(49%),还有关于在肝脏诊断后了解酒精相关健康影响的叙述性评论。大多数患者认为,与健康警示标签(33%)和商业广告中的安全信息(39%)相比,初中/高中水平的公共卫生教育具有长期效果(72%)。只有20%的患者认为当前的公共教育足够,73%的患者支持健康警示标签。
肝移植患者报告对酒精相关健康影响的知晓率较高,但并非普遍知晓。大多数人认为当前的公共卫生努力不足;实施公共卫生干预措施以确保消费者能够就酒精消费做出明智决策至关重要。